MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.brachy.2022.11.005

Медицинская библиотека · Brachytherapy · 2022

Comparing dosimetry of locally advanced cervical cancer patients treated with 3 versus 4 fractions of MRI-guided brachytherapy.

Scott Aba Anoa, Weersink Madrigal, Liu Zhihui Amy, Milosevic Michael, Croke Jennifer, Fyles Anthony, Lukovic Jelena, Rink Alexandra, Beiki-Ardakani Akbar, Borg Jette, Xie Jason, Chan Kitty, Ballantyne Heather, Skliarenko Julia, Conway Jessica L, Gladwish Adam, Weersink Robert A, Han Kathy

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

PURPOSE: To demonstrate the feasibility of treating cervical cancer patients with MRI-guided brachytherapy (MRgBT) using 24 Gy in 3 fractions (F) versus a standard, more resource-intensive regimen of 28 Gy in 4F, and its ability to meet EMBRACE II planning aims.

METHODS AND MATERIALS: A retrospective review of 224 patients with FIGO Stage IB-IVA cervical cancer treated with 28 Gy/4F (n = 91) and 24 Gy/3F (n = 133) MRgBT between 2016-2021 was conducted. Multivariable linear regression models were fitted to compare dosimetric parameters between the two groups, adjusting for CTVHR and T stage.

RESULTS

Most patients had squamous cell carcinoma, T2b disease, and were treated with intracavitary applicator plus interstitial needles (96%). The 28 Gy/4F group had higher CTVHR (median 28 vs. 26 cm3, p = 0.04), CTVIR D98% (mean 65.5 vs. 64.5 Gy, p = 0.03), rectum D2cm3 (mean 61.7 vs. 59.2 Gy, p = 0.04) and bladder D2cm3 (81.3 vs. 77.9 Gy, p = 0.03). There were no significant differences in the proportion of patients meeting the EMBRACE II OAR dose constraints and planning aims, except fewer patients treated with 28 Gy/4F met rectum D2cm3 < 65 Gy (73 vs. 85%, p = 0.027) and ICRU rectovaginal point < 65 Gy (65 vs. 84%, p = 0.005).

CONCLUSIONS

Cervical cancer patients treated with 24 Gy/3F MRgBT had comparable target doses and lower OAR doses compared to those treated with 28 Gy/4F. A less-resource intense fractionation schedule of 24 Gy/3F is an alternative to 28 Gy/4F in cervix MRgBT.

Для цитирования: Scott Aba Anoa, Weersink Madrigal, Liu Zhihui Amy, Milosevic Michael, Croke Jennifer, Fyles Anthony, Lukovic Jelena, Rink Alexandra, Beiki-Ardakani Akbar, Borg Jette, Xie Jason, Chan Kitty, Ballantyne Heather, Skliarenko Julia, Conway Jessica L, Gladwish Adam, Weersink Robert A, Han Kathy. Comparing dosimetry of locally advanced cervical cancer patients treated with 3 versus 4 fractions of MRI-guided brachytherapy.. Brachytherapy. 2022. DOI: 10.1016/j.brachy.2022.11.005.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.